This clinical quality registry aims to improve myeloma outcomes by providing an evidence base for the best strategies to diagnose, treat and support people with myeloma and related diseases.
Patients with multiple myeloma
Number of approved sites
FRAIL-M, a trial using MRDR infrastructure, has commenced recruitment.Read more
Dr Jessie Zhao's presentation on treatment patterns in myeloma was awarded a Snowdome travel grant.Read more
The MRDR was well represented at the Blood 2019 conference in Perth in October.Read more